DiDi Global Income from Continuous Operations 2021-2021 | DIDIY
DiDi Global annual/quarterly income from continuous operations history and growth rate from 2021 to 2021. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- DiDi Global income from continuous operations for the quarter ending September 30, 2021 was $-4.714B, a INF% decline year-over-year.
- DiDi Global income from continuous operations for the twelve months ending September 30, 2021 was $-3.877B, a INF% decline year-over-year.
- DiDi Global annual income from continuous operations for 2023 was $0.075B, a 102.19% decline from 2022.
- DiDi Global annual income from continuous operations for 2022 was $-3.448B, a 55.46% decline from 2021.
- DiDi Global annual income from continuous operations for 2021 was $-7.742B, a 378.17% increase from 2020.
| DiDi Global Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2023 | $75 |
| 2022 | $-3,448 |
| 2021 | $-7,742 |
| 2020 | $-1,619 |
| DiDi Global Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2021-09-30 | $-4,714 |
| 2021-03-31 | $837 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $18.956B | $27.096B |
| DiDi Global Inc. provides mobility technology platform. It offers app-based services across Asia Pacific, Latin America and Africa as well as in Central Asia and Russia, including ride hailing, taxi hailing, chauffeur, hitch and other forms of shared mobility as well as auto solutions, food delivery, intra-city freight and financial services. DiDi Global Inc. is based in BEIJING. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.093B | 15.25 |
| Cencora (COR) | United States | $45.021B | 17.20 |
| ICON (ICLR) | Ireland | $24.951B | 22.42 |
| Avantor (AVTR) | United States | $18.396B | 27.90 |
| Natera (NTRA) | United States | $15.720B | 0.00 |
| Revvity (RVTY) | United States | $15.367B | 26.91 |
| Viatris (VTRS) | United States | $14.203B | 4.33 |
| CochLear (CHEOY) | Australia | $12.751B | 0.00 |
| Solventum (SOLV) | United States | $12.458B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.201B | 33.99 |
| Charles River Laboratories (CRL) | United States | $10.641B | 20.11 |
| Sonic Healthcare (SKHHY) | Australia | $8.811B | 0.00 |
| Doximity (DOCS) | United States | $7.438B | 47.13 |
| Bausch + Lomb (BLCO) | Canada | $7.041B | 30.30 |
| HealthEquity (HQY) | United States | $6.771B | 36.75 |
| PACS (PACS) | United States | $6.218B | 0.00 |
| Organon (OGN) | United States | $5.142B | 5.23 |
| Life Times (LTH) | United States | $4.879B | 40.78 |
| Sotera Health (SHC) | United States | $4.741B | 23.91 |
| Surgery Partners (SGRY) | United States | $4.088B | 45.30 |
| Concentras Parent (CON) | United States | $2.955B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.789B | 105.00 |
| BrightSpring Health Services (BTSG) | United States | $2.550B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.438B | 0.00 |
| Progyny (PGNY) | United States | $2.206B | 38.79 |
| Alignment Healthcare (ALHC) | United States | $2.177B | 0.00 |
| Premier (PINC) | United States | $2.052B | 9.23 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.921B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.778B | 8.93 |
| Agilon Health (AGL) | United States | $1.642B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.556B | 0.00 |
| CareDx (CDNA) | United States | $1.543B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.183B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.044B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
| Pediatrix Medical (MD) | United States | $0.933B | 10.15 |
| Embecta (EMBC) | United States | $0.895B | 5.97 |
| InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.551B | 0.00 |
| Sharecare (SHCR) | United States | $0.527B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.499B | 0.00 |
| Enhabit (EHAB) | United States | $0.410B | 35.48 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| DocGo (DCGO) | United States | $0.361B | 13.58 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| Biodesix (BDSX) | United States | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.226B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.194B | 0.00 |
| ModivCare (MODV) | United States | $0.192B | 6.11 |
| Beauty Health (SKIN) | United States | $0.187B | 0.00 |
| MultiPlan (MPLN) | United States | $0.152B | 0.00 |
| Nutex Health (NUTX) | United States | $0.126B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.083B | 0.00 |
| So-Young (SY) | China | $0.081B | 19.72 |
| Singular Genomics Systems (OMIC) | United States | $0.042B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.66 |
| Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | $0.008B | 0.00 | |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |